Safety of COVID-19 Vaccination in Inflammatory Bowel Disease Patients on Biologic Therapy.
作者信息
Garrido Isabel, Lopes Susana, Macedo Guilherme
机构信息
Gastroenterology and Hepatology Department, Centro Hospitalar e Universitário de São João, Porto, Portugal.
World Gastroenterology Organization (WGO) Porto Training Center, Porto, Portugal.
出版信息
J Crohns Colitis. 2022 May 10;16(4):687-688. doi: 10.1093/ecco-jcc/jjab189.
Abstract
摘要
相似文献
1
Safety of COVID-19 Vaccination in Inflammatory Bowel Disease Patients on Biologic Therapy.接受生物治疗的炎症性肠病患者接种新冠疫苗的安全性
J Crohns Colitis. 2022 May 10;16(4):687-688. doi: 10.1093/ecco-jcc/jjab189.
2
COVID-19 Vaccination in Patients With Inflammatory Bowel Disease and History of Reaction to Injectable Therapies.炎症性肠病患者及有注射疗法反应史患者的新冠病毒疫苗接种情况
Inflamm Bowel Dis. 2021 Jul 27;27(8):1358-1360. doi: 10.1093/ibd/izab094.
3
SARS-CoV-2 vaccination uptake by patients with inflammatory bowel disease on biological therapy.炎症性肠病患者接受生物治疗时对SARS-CoV-2疫苗的接种情况。
Lancet Gastroenterol Hepatol. 2021 Dec;6(12):989. doi: 10.1016/S2468-1253(21)00347-2. Epub 2021 Oct 14.
4
Risk of adverse events and reported clinical relapse after COVID-19 vaccination in patients with IBD.炎症性肠病患者接种新冠疫苗后出现不良事件及报告的临床复发风险。
Gut. 2022 Sep;71(9):1926-1928. doi: 10.1136/gutjnl-2021-326237. Epub 2021 Nov 24.
5
COVID-19 mRNA Vaccine Short-Term Safety in Patients With Inflammatory Bowel Disease.炎症性肠病患者中COVID-19 mRNA疫苗的短期安全性
Gastroenterology. 2022 Mar;162(3):987-988. doi: 10.1053/j.gastro.2021.10.004. Epub 2021 Oct 6.
6
Winter Is Coming! Clinical, Immunologic, and Practical Considerations for Vaccinating Patients With Inflammatory Bowel Disease During the Coronavirus Disease-2019 Pandemic.寒冬将至！2019冠状病毒病大流行期间炎症性肠病患者疫苗接种的临床、免疫学及实际考量
Gastroenterology. 2021 Feb;160(3):639-644. doi: 10.1053/j.gastro.2020.10.013. Epub 2020 Oct 14.
7
[SARS-CoV-2 Vaccination for Adult Patients with Inflammatory Bowel Disease: Expert Consensus Statements by KASID].[成人炎症性肠病患者的新型冠状病毒2型疫苗接种：韩国炎症性肠病学会专家共识声明]
Korean J Gastroenterol. 2021 Aug 25;78(2):117-128. doi: 10.4166/kjg.2021.110.
8
Immune Response Induced by SARS-CoV-2 Vaccines in Patients With Inflammatory Bowel Disease Under Biologic Therapy.生物治疗下炎症性肠病患者接种SARS-CoV-2疫苗后的免疫反应
Am J Gastroenterol. 2022 Mar 1;117(3):504-505. doi: 10.14309/ajg.0000000000001630.
9
[Covid-19 vaccination and risk of anaphylaxis - Recommendations for practical management].[新冠病毒-19疫苗接种与过敏反应风险——实际管理建议]
MMW Fortschr Med. 2021 Jan;163(1):48-51. doi: 10.1007/s15006-021-9530-6.
10
Myocarditis Temporally Associated With COVID-19 Vaccination.心肌炎与 COVID-19 疫苗接种相关。
Circulation. 2021 Aug 10;144(6):502-505. doi: 10.1161/CIRCULATIONAHA.121.055891. Epub 2021 Jun 16.
引用本文的文献
1
Clinical characteristics and the risk factors for the exacerbation of symptoms in patients with inflammatory bowel disease during the COVID-19 pandemic.COVID-19大流行期间炎症性肠病患者的临床特征及症状加重的危险因素
Front Med (Lausanne). 2024 Jun 5;11:1404880. doi: 10.3389/fmed.2024.1404880. eCollection 2024.
2
The association of three vaccination doses with reduced gastrointestinal symptoms after severe acute respiratory syndrome coronavirus 2 infections in patients with inflammatory bowel disease.炎症性肠病患者感染严重急性呼吸综合征冠状病毒2后，三剂疫苗接种与胃肠道症状减轻之间的关联。
Front Med (Lausanne). 2024 Mar 18;11:1377926. doi: 10.3389/fmed.2024.1377926. eCollection 2024.
3
Disease Flares Following COVID-19 Vaccination in Patients with Inflammatory Bowel Disease.炎症性肠病患者接种 COVID-19 疫苗后的疾病发作。
Intern Med. 2023 Dec 15;62(24):3579-3584. doi: 10.2169/internalmedicine.2335-23. Epub 2023 Sep 29.
4
COVID-19 Vaccines for Adults and Children with Autoimmune Gut or Liver Disease.适用于患有自身免疫性肠道或肝脏疾病的成人和儿童的新冠疫苗。
Vaccines (Basel). 2022 Dec 5;10(12):2075. doi: 10.3390/vaccines10122075.
5
Impact of Anti-TNFα Treatment on the Humoral Response to the BNT162b2 mRNA COVID-19 Vaccine in Pediatric Inflammatory Bowel Disease Patients.抗TNFα治疗对儿童炎症性肠病患者针对BNT162b2 mRNA新冠疫苗的体液免疫反应的影响
Vaccines (Basel). 2022 Sep 27;10(10):1618. doi: 10.3390/vaccines10101618.
6
Comparison the effects and side effects of Covid-19 vaccination in patients with inflammatory bowel disease (IBD): a systematic scoping review.比较 COVID-19 疫苗接种在炎症性肠病（IBD）患者中的效果和副作用：系统范围综述。
BMC Gastroenterol. 2022 Aug 20;22(1):393. doi: 10.1186/s12876-022-02460-1.
7
Safety of SARS-CoV-2 vaccination in patients with inflammatory bowel disease: A systematic review and meta-analysis.新型冠状病毒疫苗在炎症性肠病患者中的安全性：系统评价和荟萃分析。
Dig Liver Dis. 2022 Jun;54(6):713-721. doi: 10.1016/j.dld.2022.03.005. Epub 2022 Mar 22.
8
Effectiveness and safety of SARS-CoV-2 vaccine in Inflammatory Bowel Disease patients: a systematic review, meta-analysis and meta-regression.新型冠状病毒疫苗在炎症性肠病患者中的有效性和安全性：系统评价、荟萃分析和荟萃回归。
Aliment Pharmacol Ther. 2022 May;55(10):1244-1264. doi: 10.1111/apt.16913. Epub 2022 Mar 30.
Zotero 插件